New Active Folic provides Folic Acid in its natural folate form to support greater absorption.
400µg of Folic Acid is recommended one month prior to conception and for the first 12 weeks to increase maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects (NTD) in the developing foetus.
Folic Acid is the most common form of folate supplement. However, increasing evidence suggests that reduced folate (methyl folate) is a better option. This is a result of the inability of up to 67% of the world’s population* to be able to effectively convert Folic Acid from food or supplements into a form that is usable in the body.